Exagen reported results for the three- and nine-month periods, but the supplied filing gives no figures showing how the business performed. It therefore does not change Exagen's outlook.
The filing points to a separate press release, but its results are not included in the text provided. Without sales, costs, or profit figures, there is no way to tell whether Exagen's business improved or weakened.
Follow Exagen Inc. (XGN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for XGN